On October 21, 2017, Health Canada publicly released its
Fee Proposal for Drugs and Medical Devices. The Service
Fee Act was introduced as part of an Omnibus Budget
2017 Bill and in the Canadian Animal Health Institute’s
opinion did not get the scrutiny it needed, particularly as it
relates to public/private good and competitiveness. Jean
Szkotnicki at CAHI describes the concerns of the Institute
about the unintended consequences of the proposed
fees, should they be introduced as is in 2019.

Comments are closed.